Transcript - Testosterone - Low-T Treatments Linked to Stroke, Heart Attack and Death
Testosterone therapy manufacturers are facing numerous lawsuits after men who were prescribed low testosterone or "low-t" treatments suffered stroke, heart attack and death. Testosterone replacement has been called a "wonder drug" for middle- aged men worried about a decline in their sexual health and energy levels. More than 5 million people in the United States are currently taking testosterone. Prescriptions have increased more than five-fold in recent years, with sales exceeding 1.6 billion dollars, surpassing Viagra. Recent studies indicate that men over 65 had a double risk of a heart attack within 90 days of starting hormone therapy. Among men under the age of 65 with a history of heart disease, there was a two-to-three fold increased risk of a heart attack and another study was discontinued due to a high rate of heart attacks.
This type of therapy is often administered as a gel, patch or injection and may include the following products: Androderm, Androgel, Axiron, Fortesta, Striant, Testim, Testoderm, Testopel, Vogelxo.
Doctors worry that these "low-t" treatments are being over-prescribed, due in part to aggressive marketing by drug manufacturers. Although the FDA is now investigating the safety of testosterone treatments, testosterone products remain on the shelf.
Our goal at Moll Law Group is to inform consumers of potentially dangerous products and provide assistance with the filing of claims. If you have a case and would like a prompt and confidential evaluation, please fill out our free consultation form. For free consumer safety information and case updates, visit us at legalnewsnetwork.com